Page Image

The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.

ESMO

Latest Episode

Episode 365: A Review of the Advanced Prostate Cancer Consensus Conference (APCCC)
Returning guests Bertrand Tombal and Silke Gillessen join the podcast to dive into some of the top take-home data from the 2024 Advanced Prostate Cancer Consensus Conference. We also discuss Dr. Gillessen’s latest publication on the management of patients with advanced prostate cancer. ...
Advertisement
Advertisement

The Uromigos: Live and Unplugged 2023

Kidney Cancer Discussions

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics

Advertisement
Advertisement
Get updates from The Uromigos straight to your inbox.